Advances in cell biology in the late 20th and early 21st centuries have given rise to a new form of medical therapy in which cells and tissues are used as healing elements.
Miami, FL (PRWEB) September 26, 2013
Stem Cell Training, Inc., a division of the Global Stem Cells Group, announced today the launch of a post-graduate diploma program with the Research Center in Tissue Engineering and Cellular Therapy at Maimonides University in Buenos Aires. The diploma program, the first of its kind worldwide, is designed for physicians and practitioners to bridge the gap between advanced laboratory practices and the practitioner’s office.
According to Gustavo Antonio Moviglia, M.D., a lead trainer for Stem Cell Training, Inc., the decision to launch the post-graduate diploma coursework has evolved out of advances in cell biology in the late 20th and early 21st centuries which have given rise to a new form of medical therapy in which cells and tissues are used as healing elements, no longer just to supplement or replace deficient or ailing cells.
Since 2000, Maimonides University and Moviglia have worked to generate scientific and medical applications based on tissue engineering and cellular therapy, to enrich this specialty and establish their own philosophy. Their work will be the basis for the postgraduate course, aiming to create academic space for training professionals and developing new knowledge in this area of medicine.
With many in the field of medical research believing cell therapy to be the central point around which future medicine will revolve, Stem Cell Training, Inc. and Maimonides University have chosen to lead the process together, providing medical professionals with the scientific and practical methodologies of this new discipline.
For more information, visit the Diplomat Tissue Engineering page of the Stem Cell Training, Inc. website.
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-224-1858.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
The Global Stem Cell Foundation was formed as a non-profit charitable organization that aims to fund research on the expanding need for stem cell solutions for patients, and identify best practices between physicians engaged in stem cell treatments in the U.S. and around the world.
To learn more about Global Stem Cells Group, Inc.’s companies, and for investor information, visit the Global Stem Cell Group Website, email info(at)regenestem(dot)com, or call 305-224-1858.